X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (6) 6
humans (6) 6
index medicus (6) 6
middle aged (5) 5
ovarian neoplasms - drug therapy (5) 5
adult (4) 4
aged (4) 4
cancer (4) 4
chemotherapy (4) 4
ovarian cancer (4) 4
ovarian neoplasms - mortality (4) 4
paclitaxel (4) 4
abridged index medicus (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
gynecologic-oncology-group (3) 3
oncology (3) 3
ovarian neoplasms - pathology (3) 3
paclitaxel - administration & dosage (3) 3
phase-iii trial (3) 3
1st-line treatment (2) 2
adenocarcinoma, clear cell - drug therapy (2) 2
aged, 80 and over (2) 2
analysis (2) 2
carboplatin (2) 2
care and treatment (2) 2
cisplatin (2) 2
cisplatin - administration & dosage (2) 2
cisplatin - adverse effects (2) 2
combined modality therapy (2) 2
cyclophosphamide (2) 2
dose-response relationship, drug (2) 2
drug therapy (2) 2
infusions, intravenous (2) 2
medicine, general & internal (2) 2
neoadjuvant chemotherapy (2) 2
neoplasm staging (2) 2
ovarian neoplasms - surgery (2) 2
paclitaxel - adverse effects (2) 2
peritoneal neoplasms - drug therapy (2) 2
research (2) 2
stage-iii (2) 2
survival analysis (2) 2
therapy (2) 2
tumors (2) 2
usage (2) 2
2-tier system (1) 1
2nd-line (1) 1
5-fu (1) 1
abdomen (1) 1
abdominal pain - chemically induced (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - surgery (1) 1
adenocarcinoma, mucinous - drug therapy (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antitumor-activity (1) 1
area under curve (1) 1
article (1) 1
bevacizumab (1) 1
bevacizumab - adverse effects (1) 1
bevacizumab - therapeutic use (1) 1
beyond progression (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - adverse effects (1) 1
camptothecin - analogs & derivatives (1) 1
cancer therapies (1) 1
carboplatin - administration & dosage (1) 1
carcinoma (1) 1
carcinoma - drug therapy (1) 1
carcinoma - pathology (1) 1
carcinoma - surgery (1) 1
carcinoma, endometrioid - drug therapy (1) 1
clinical trials (1) 1
comparative analysis (1) 1
continuation (1) 1
continued treatment (1) 1
cpt-11 (1) 1
crm (1) 1
cystadenocarcinoma, serous - drug therapy (1) 1
cystadenocarcinoma, serous - mortality (1) 1
cystadenocarcinoma, serous - pathology (1) 1
cystadenocarcinoma, serous - therapy (1) 1
debulking surgery (1) 1
development and progression (1) 1
disease progression (1) 1
dna topoisomerase-i (1) 1
drug (1) 1
drug administration schedule (1) 1
drug resistance, neoplasm (1) 1
drug therapy, combination (1) 1
epithelial ovarian cancer (1) 1
expression (1) 1
fallopian tube neoplasms - drug therapy (1) 1
fallopian tube neoplasms - mortality (1) 1
family medical history (1) 1
fluorouracil - administration & dosage (1) 1
fluorouracil - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2006, Volume 354, Issue 1, pp. 34 - 43
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 07/2018, Volume 18, Issue 1, pp. 771 - 771
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/1999, Volume 17, Issue 8, pp. 2553 - 2561
Purpose: Twenty-one-day topotecan infusion was administered as second-line therapy in patients with previously treated ovarian cancer (based on our prior... 
DRUG | PHASE-II | ONCOLOGY | DNA TOPOISOMERASE-I | PACLITAXEL
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.